Monday, June 15

Posters
Learn more.

Branding and Influence for Critical Change in Challenging Times
Planned in cooperation with the ASHP Foundation Center for Health-System Pharmacy Leadership
Leading the Pharmacy Enterprise in Challenging Times Learning Community
ACPE Program #204-000-09-102-L04P
2.0 Contact Hours / Application-based
Moderator:  Sharon M. Enright, RPh, MBA, President, Envision Change, Richmond, VA

With an environment of change that is both dynamic and incessant, every leader (small l intentional) needs to be conscious to the opportunity to influence change and to take advantage of opportunities to impact organizational transformation, patient safety and quality of care.  With no shortage of ideas—good and bad—of how to change, some ideas become mainstream, some new concepts get legs, some get funded, and some fail. How we are perceived and how we influence others—as individuals and as a departmental team—affects how well we can execute our vision and achieve results.  This session will explore the critical concepts of personal and departmental branding as strategies for increasing personal and organizational effectiveness.  Transforming a brand, and building brand strength and stature are explored in the context of the traditional “pharmacy” brand and some of the brand challenges we face.

Learning Objectives:

• Define and apply personal branding techniques and their importance to effective leadership of the pharmacy enterprise.
• Apply five savvy leadership and branding component elements to sound strategic and tactical leadership approaches.
• Evaluate your personal brand and apply key principles to building a personal development plan for your brand.

8:00 a.m. – 8:15 a.m.
Announcements

8:15 a.m – 10:00 a.m.
Building a Personal and Organizational Leadership Brand and Influencing Skills
John Daly, PhD, Professor, University of Texas, Austin
James A. Jorgenson, RPh, MS, FASHP, Executive Director of Pharmacy, Clarian Health Partners, Indianapolis, IN

Crash Course:  Recent Landmark Papers You Need to Know About
Planned in cooperation with the ASHP Quality Improvement Initiative
Quality Standards in Clinical Practice Series
ACPE Program #204-000-09-103-L01P
2.0 Contact Hours / Application-based
Moderator:  Joseph J. Saseen, PharmD, Associate Professor, University of Colorado Denver, Aurora

Bring yourself up to date!  Get the latest on critical trials you need to know about.  Get the scoop about the trials, research, and their implications for your practice.

Learning Objectives:

• Identify current research that is significant for pharmacy practice.
• Summarize key findings of selected landmark papers.
• Define implications of the findings for pharmacy practice and your setting.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 8:55 a.m.
Landmark Papers: Focusing on Chronic Cardiovascular Care
Joseph J. Saseen

8:55 a.m. – 9:45 a.m.
Landmark Papers: Focusing on Acute Cardiovascular Care
Joel C. Marrs, PharmD, BCPS, Clinical Assistant Professor, Oregon State University/Oregon Health & Science University, Portland; and Clinical Pharmacy Specialist, Oregon Health & Science University Hospital and Clinics, Portland

9:45 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

National Patient Safety Goal in Anticoagulation Update 2009
Anticoagulation Series
ACPE Program #204-000-09-104-L03P
2.0 Contact Hours / Application-based
Moderator:  William E. Dager, PharmD, Pharmacist Specialist, UC Davis Medical Center, Sacramento, CA

How is it going with the implementation of the National Patient Safety Goal (NPSG) on anticoagulation?   Get updated on the status of the NPSG on anticoagulation and approaches to developing a successful program.  Assess where you stand and how you can help your institution improve in the safe use of anticoagulants.

Learning Objectives:

• Explain the status and most current issues in the implementation of the National Patient Safety Goal (NPSG) on anticoagulation.
• Assess your progress in implementing the NPSG on anticoagulation.
• Explain challenges and solutions to improved implementation of the NPSG on anticoagulation.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 8:30 a.m.
Update on the Implementation of The Joint Commission Anticoagulation National Patient Safety Goal
Darryl S. Rich, PharmD, MBA, FASHP, Surveyor, The Joint Commission, Oakbrook Terrace, IL

8:30 a.m.– 8:45 a.m.
Questions, Answers, and Discussion

8:45 a.m. – 9:15 a.m.
Justification and Implementation of an Anticoagulation Program: Partnering with Hospital Administration for Success
Sean T. O'Grady, FACHE, Senior Vice President, Northshore University HealthSystem, Evanston, IL

9:15 a.m. – 9:45 a.m.
Standardizing Approaches to Anticoagulation Management in Your System
Ann K. Wittkowsky, PharmD, FCCP, FASHP, Clinical Professor, University of Washington School of Pharmacy, Seattle; and Director, Anticoagulation Services, University of Washington Medical Center, Seattle

9:45 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

Healthcare Informatics: Quality Improvement through CPOE and the Electronic Health Record
Informatics Series
ACPE Program #204-000-09-105-L04P / 204-000-09-105-L04T
2.0 Contact Hours / Application-based
Moderator:  Brent I. Fox, PharmD, PhD, Assistant Professor, Auburn University Harrison School of Pharmacy, Auburn, AL

Information technology is viewed as a tool to assist in the improvement of healthcare delivery.  It allows for data presentation, collection, and analysis to support healthcare providers.  Information technology can also support documentation necessary for regulatory requirements.  This session will focus on Computerized Physician Order Entry (CPOE) as a method to achieve quality improvement initiatives facing health systems today.

Learning Objectives:

• Define quality measures reportable to Centers for Medicare and Medicaid Services, The Joint Commission, and other regulatory agencies and advocacy groups.
• Describe the role of Computerized Physician Order Entry (CPOE) as an enabling technology for quality improvement initiatives.
• Describe the role of pharmacy informatics staff in institutional quality improvement initiatives utilizing CPOE.
• Explain successful and unsuccessful strategies to implement information systems to support Quality Initiative (QI) efforts.
• Describe the desirable quality improvement reports of a CPOE information technology implemented as party of a QI effort.

8:00 a.m. – 8:05 a.m.
Announcements

8:05 a.m. – 8:10 a.m.
Table Discussions: Quality/Regulatory Challenges

8:10 a.m. – 8:40 a.m.
Introduction to Technology Enabled Quality Improvements
Katie DeJuras, BSN, MSN, Clinical Informatics Nurse, Northwestern Memorial Hospital, Chicago, IL

8:40 a.m. – 9:10 a.m.
Informatics Pharmacist’s Role in Quality Improvement Initiatives
Anne M. Bobb, BS Pharm, Clinical Informatics Pharmacist, Northwestern Memorial Hospital, Chicago, IL

9:10 a.m. – 9:40 a.m.
Physician Perspective and Data Driven Improvements
David Liebovitz, MD, Medical Director for Clinical Information Systems, Northwestern Memorial Hospital, Chicago, IL; and CMIO, Northwestern Medical Faculty Foundation, Chicago, IL

9:40 a.m. – 9:50 a.m.
Presentation and Discussion of Challenges Identified at Table Discussion

9:50 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

New Drugs in Primary Care 2009
Hot Topic
ACPE Program #204-000-09-106-L01P
1.5 Contact Hours / Knowledge-based
Faculty:  J. Thomas Frank, PharmD, BS, Associate Professor of Pharmacy Practice, Area Health Education Center Northeast, Jonesboro, AR

As drug therapy experts, pharmacists are often called upon for facts and opinions about recently introduced drugs.  This presentation is intended to provide a broad-based discussion and objective information about new drug options, including cost information, to be considered by your Pharmacy and Therapeutics Committee.

Learning Objectives:

• Assess new trends in drug development.
• Explain indications, pharmacology, adverse effects, and dosing of the products discussed.
• Determine the role these products will play in your practice.
• Evaluate the economic implications of these choices.
• Examine products in the short-term pipeline that will be important to your practice.

8:30 a.m. – 8:35 a.m.
Announcements

8:35 a.m. – 9:55 a.m.
New Drugs in Primary Care 2009

9:55 a.m. – 10:00 a.m.
Questions, Answers, and Discussion

Opening Session

Presidential Address:  Kevin J. Colgan, MA, RPh, FASHP, Senior Vice President of Health Economics and Outcomes Research, EPI-Q, Inc., Oakbrook, IL

Acknowledgement of the 2009 Harvey A.K. Whitney Award Recipient:  Paul W. Abramowitz, PharmD, FASHP, Director of Pharmacy, University of Iowa Hospitals and Clinics; and Professor and Assistant Dean, University of Iowa College of Pharmacy, Iowa City

Keynote Address: Howard Putnam
In an engaging address that explores how leaders can help their organizations survive and thrive through turbulence, Mr. Putnam shares inspiring examples and behind-the-scenes experiences from the business success stories that mark his long and distinguished career in aviation. Learn more.

Exhibit Program
Learn more.

Meet the Experts
Consult with big names in pharmacy.  Head for the Exhibit Hall, where pharmacy experts are stationed at tables, each labeled with their area of expertise.  Choose an expert in an area important to you and ask your burning questions. Learn more.

Meet the Candidates—Candidates for ASHP Offices to Go On-the-Record

Posters Presentations
Poster presenters will be at their posters ready to answer your questions. Learn more.

Building Branding and Influence Skills
Planned in cooperation with the ASHP Foundation Center for Health-System Pharmacy Leadership
Leading the Pharmacy Enterprise in Challenging Times Learning Community
ACPE Program #204-000-09-107-L04P
3.0 Contact Hours / Application-based
Moderator:  Sharon M. Enright, RPh, MBA, President, Envision Change, Richmond, VA

Ideas have consequences when they are memorable and when persuasively presented and marketed.  Every organization is a market place of ideas, and those ideas that survive to implementation get adopted because their value was clear, timely, and relevant.  In the race to—increasingly limited—resources, the ability to wield influence, to be persuasive, and to advocate for change concepts is an increasingly critical leadership asset in today’s complex healthcare environment.  This highly interactive session will provide key concepts, strategies, and tactics you can employ to build your influence and persuasion skills and to fine-tune your role as an advocate for change.  Smaller group breakouts will offer facilitated discussions for affinity groups to address building on personal branding, explore departmental brands enhancement, and application of influence skills to the demands of a challenging environment.  Participants will use exercises to assess their traditional and evolving departmental branding within the larger organization, and strategize how to transform their personal and departmental brands to increase their influence and advocacy on key issues.

Learning Objectives:

• Develop a personal action plan for building and refining departmental branding skills.
• Apply newly learned storytelling elements and skills to build core elements of a brand message for departmental branding.
• Identify potential impact of sources of influence and apply to the development of a preliminary plan for building influence skills in your workforce.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 3:00 p.m.
Building Branding and Influencing Skills
John Daly, PhD, Professor, University of Texas, Austin
James A. Jorgenson, RPh, MS, FASHP, Executive Director of Pharmacy, Clarian Health Partners, Indianapolis, IN

3:00 p.m. – 3:20 p.m.
Introduction to Breakout Groups

3:20 p.m. – 3:30 p.m.
Move into Breakout Groups

3:30 p.m. – 4:45 p.m.
Breakout Groups by Functional Area
Steven R. Abel, BS, PharmD, FASHP, Assistant Dean for Clinical Programs; and Bucke Professor and Head, Department of Pharmacy Practice, Purdue University, Indianapolis, IN
James A. Jorgenson, RPh, MS, FASHP, Executive Director of Pharmacy, Clarian Health Partners, Indianapolis, IN
Despina Kotis, PharmD, Northwestern Memorial Hospital, Chicago, IL
Sara J. White, MS, FASHP, Pharmacy Leadership Coach, Mountain View, CA

4:45 p.m. – 5:00 p.m.
Wrap Up and Introduction to Tuesday’s Sessions

Perspectives in Preventing and Treating Thrombosis with Anticoagulant Medications
Anticoagulation Series
ACPE Program #204-000-09-108-L01P
3.0 Contact Hours / Application-based
Moderator:  William E. Dager, PharmD, Pharmacist Specialist, UC Davis Medical Center, Sacramento, CA

Get the latest on new anticoagulants, expanding the pharmacist’s role, and challenges with the Surgery Care Improvement Project guidelines, and upcoming venous thromboembolism measures from The Joint Commission.

Learning Objectives:

• Explain select issues related to the Surgery Care Improvement Project (SCIP) and the pending venous thromboembolism (VTE) measures.
• Describe the newest anticoagulants and their impact on pharmacy systems and safe anticoagulation.
• Describe how to measure impact and adapt the use of anticoagulation therapy.
• Identify potential roles for pharmacists in managing thromboembolic disease and anticoagulation.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:45 p.m.
Exploring How SCIP Guidelines and Pending VTE Measures from The Joint Commission Will Impact Anticoagulation Therapy
Edith Nutescu, PharmD, FCCP, Clinical Associate Professor; and Director, Antithrombosis Center, University of Illinois at Chicago

2:45 p.m. – 3:15 p.m.
Exploring Expanded Practice Roles for Pharmacists in Managing Current and Future Anticoagulant Therapy
William E. Dager

3:15 p.m. – 3:30 p.m.
Questions, Answers, and Discussion

3:30 p.m. – 3:40 p.m.
Break

3:40 p.m. – 4:20 p.m.
Optimal Anticoagulation Management Approaches
William E. Dager
Michael Gulseth, PharmD, BCPS, Program Director of Anticoagulation Services, Sanford USD Medical Center, Sioux Falls, SD

4:20 p.m. – 4:50 p.m.
Challenges in Measuring the Use of Anticoagulant Medications in Your System and Adjusting Practice
John Fanikos, RPh, MBA, Assistant Director of Pharmacy, Brigham and Women’s Hospital, Boston, MA

4:50 p.m. – 5:00 p.m.
Questions, Answers, and Discussion

IV Safety: Preventing Death and Harm from IV Medication Errors
Planned in cooperation with the ASHP Quality Improvement Initiative
Quality Standards in Clinical Practice Series
ACPE Program #204-000-09-109-L05P
3.0 Contact Hours / Application-based
Moderator:  Bona E. Benjamin, BS Pharm, Director, Medication-Use Quality Improvement, American Society of Health-System Pharmacists, Bethesda, MD

If we know how to prevent harmful or fatal intravenous medication errors, why do they continue to occur? Can a serious IV medication error happen at your organization? What are the essential practices for preventing harm from intravenous medication errors?  Can a diverse group of physicians, nurses, pharmacists, safety experts, industry representatives, and healthcare leaders achieve consensus on the best approach?  Most importantly, what actions are needed to make real and sustained improvements in intravenous medication use safety?  Find out how standardizing concentrations creates savings and efficiencies.

Learning Objectives:

• Summarize key findings on intravenous medication safety from ASHP’s IV Safety Summit.
• Explain how to plan and conduct an organizational assessment for intravenous medication-use safety.
• Develop a strategy for organization-wide improvement of the safety of intravenous medication use.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:25 p.m.
Overview of Findings from the IV Safety Summit:  Best Practices
Bona E. Benjamin

2:25 p.m. – 2:55 p.m.
Performing an Organization-Wide IV Safety Self-Assessment
Allen J. Vaida, BSc, PharmD, FASHP, Executive Vice President, Institute for Safe Medication Practices, Horsham, PA 

2:55 p.m. – 3:30 p.m.
Essential Concepts and Practical Recommendations for Improving IV Safety – Interactive Case Study
Frank A. Federico, BS, Executive Director, Institute for Healthcare Improvement, Cambridge, MA

3:30 p.m. – 4:15 p.m.
Is IV Medication Use Safe in Your Hospital?  Group Exercise:  Improving Specific Areas of IV Safety
Allen J. Vaida
Frank A. Federico
Bona E. Benjamin

4:15 p.m. – 4:45 p.m.
Group Exercise:  Developing an Effective Action Plan for IV Safety
Frank A. Federico
Allen J. Vaida
Bona E. Benjamin

4:45 p.m. – 5:00 p.m.
Questions, Answers, and Discussion

Implementation of New Technology: Planning for the Changing Roles and New Opportunities for Pharmacists and Technicians
Informatics Series
ACPE Program #204-000-09-110-L04P / 204-000-09-110-L04T
3.0 Contact Hours / Application-based
Moderator:  Christopher Fortier, PharmD, Manager, Pharmacy Support Services, Medical University of South Carolina, Charleston

Hospitals are faced with technology implementations, but where are the pharmacy informaticists trained to carry out these projects?  What formal training is available?  Once your staff has been trained and systems have been implemented, what impact is there on the pharmacy department?  Are pharmacists twiddling their thumbs after implementing Computerized Physician Order Entry (CPOE), or are they freed up to focus on clinical activities?  In this session learn the status of pharmacy informatics education and training, and identify the impact of technology implementation on pharmacy personnel.

Learning Objectives:

• Describe pharmacy informatics education and training opportunities.
• Describe the evolving roles of pharmacy informaticists.
• Explain how to prepare staff for their changing roles necessary for successful technology implementation.
• Describe the impact of technology implementation on pharmacy personnel.
• Explain steps for enabling technicians to take on increasing responsibility for managing automation in the pharmacy.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:55 p.m.
Pharmacy Informatics Education, Training, and Evolving Roles
Terry L. Seaton, PharmD, BCPS, Interim Assistant Dean for Research, St. Louis College of Pharmacy, St. Louis, MO

2:55 p.m. – 3:45 p.m.
Workflows: How to Get from Here to There
Sandi H. Mitchell, BS Pharm, MSIS, Senior Consultant, maxIT Healthcare, Rosedale, MD; and Assistant Clinical Professor, University of Maryland, School of Pharmacy, Baltimore

3:45 p.m. – 4:40 p.m.
Impact of Evolving Technology on Clinical Pharmacists and Other Pharmacy Personnel
Lance J. Oyen, BS, PharmD, Assistant Director Clinical Pharmacy Services and Critical Care Clinical Pharmacist, Mayo Clinic, Rochester, MN

4:40 p.m. – 5:00 p.m.
Questions, Answers, and Discussion

Helping Safety-Net Providers Control Drug Expenditures:  The 340B Drug Pricing Program
Hot Topic
ACPE Program #204-000-09-111-L04P
3.0 Contact Hours / Knowledge-based
Moderator:  Christopher A. Hatwig, MS, RPh, Vice President, Apexus/340B Prime Vendor Program, Irving, TX

Attendees will learn about pending 340B legislation and the Health Resources and Services Administration’s (HRSA) recently published Federal Register Notices (FRNs) regarding definitions of patient, multiple contract pharmacies, and children’s hospitals.  Pharmacy leaders will share their experiences in making adjustments in their pharmacy programs to comply with the new FRNs.  Apexus, HRSA's 340B Prime Vendor, will provide an update on the latest developments with the program, which has improved access to affordable medications for participants.  Pending investigations, litigation, and Medicaid audits involving the pharmaceutical industry and covered entities will also be discussed.

Learning Objectives:

• Describe key changes within the Federal Register Notices and their implications for covered entities' outpatient pharmacy operations.
• Describe the latest developments with the 340B Prime Vendor Program and value delivered to participating 340B covered entities.
• Explain the implications that pending litigation and investigations may have on the pharmacy operations of disproportionate share hospitals.

2:00 p.m. – 2:05 p.m.
Announcements

2:05 p.m. – 2:40 p.m.
HRSA’s 340B Program and Patient Safety and Clinical Pharmacy Services Collaborative Updates
Jimmy R. Mitchell, RPh, MPH, Director, Office of Pharmacy Affairs, Health Resources and Services Administration, Rockville, MD
Krista M. Pedley, PharmD, MS, Improvement Advisor, Office of Pharmacy Affairs, Health Resources and Services Administration, Rockville, MD

2:40 p.m. – 3:05 p.m.
Pharmacy Services Support Center Update
Lisa Scholz, PharmD, MBA, Senior Director, HRSA Pharmacy Services Support Center, American Pharmacists Association, Washington, DC

3:05 p.m. – 3:30 p.m.
340B Prime Vendor Program: Adding Value
Christopher A. Hatwig

3:30 p.m. - 3:35 p.m.
Break

3:35 p.m. – 4:00 p.m.
340B Legislative Update
William H. von Oehsen, JD, President and General Counsel, Safety Net Hospitals for Pharmaceutical Access, Washington, DC; and Principal, Powers Pyles Sutter & Verville, PC, Washington, DC

4:00 p.m. – 4:45 p.m.
Pearls in Managing a 340B Pharmacy to Optimize Savings in Tough Economic Times

4:00 p.m. – 4:15 p.m.
Burnis D. Breland, MS, PharmD, FASHP, Director of Pharmacy, Columbus Regional Healthcare System, Columbus, GA

4:15 p.m. – 4:30 p.m.
Michael V. Benedict, RPh, MS, Senior Director of Pharmacy, Denver Health and Hospital Authority, Denver, CO

4:30 p.m. – 4:45 p.m.
Petra A. Fippen, RPh, Pharmacy Manager, Inventory, Contracting, and Patient Assistance Programs, Wishard Health Services, Indianapolis, IN

4:45 p.m. – 5:00 p.m.
Questions, Answers, and Discussion

Pharmacy Informatics and Technology Networking Session:  Update and Future Imperatives
Learn more.

Delegate Reception
Open to delegates and alternate delegates.

Industry-Supported Symposia
Learn more.

Monday Evening’s Night-on-the-Town!
Experience the excitement of downtown Chicago.  ASHP is providing free shuttle service from/ to the Convention Center Main Lobby and downtown Chicago.  Schedule is subject to change.  Learn more.